- Roche receives FDA clearance on its digital pathology solution for diagnostic use
- Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
- Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Key statistics
As of last trade Chugai Pharmaceutical Co Ltd (4519:TYO) traded at 6,011.00, -10.24% below its 52-week high of 6,697.00, set on Mar 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5,850.00 |
---|---|
High | 6,012.00 |
Low | 5,836.00 |
Bid | 6,011.00 |
Offer | 6,012.00 |
Previous close | 5,786.00 |
Average volume | 3.09m |
---|---|
Shares outstanding | 1.68bn |
Free float | 673.12m |
P/E (TTM) | 28.48 |
Market cap | 9.48tn JPY |
EPS (TTM) | 198.34 JPY |
Annual div (ADY) | 80.00 JPY |
---|---|
Annual div yield (ADY) | 1.42% |
Div ex-date | Dec 28 2023 |
Div pay-date | Mar 29 2024 |
Data delayed at least 20 minutes, as of Jul 03 2024 06:34 BST.
More ▼